Hayes KC. Neuropsychiatr Dis Treat. 2011;7:229-39.
A good summary of Dalfampridine (formerly fampridine) use in MS.
Click here to download PDF of article.
“It is a great pity we don’t have access to this drug; several of my patients may benefit from its use.”
COI: I have received a one-off consultancy payment from Biogen-Idec in relation to EMA’s negative decision concerning the licensing of Dalfampridine in Europe.